# Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma

> **NCT00047021** · PHASE2 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **BIOLOGICAL:** sargramostim
- **DRUG:** cytarabine
- **DRUG:** mitoxantrone hydrochloride

## Key facts

- **NCT ID:** NCT00047021
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2005-08
- **Final completion:** 2005-09
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2010-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00047021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00047021, "Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00047021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*